Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-64264681 is a potent, orally active, selective, and irreversible covalent inhibitor of Bruton's tyrosine kinase (BTK). This compound demonstrates favorable pharmacokinetic properties and is applicable in the research of cancer and autoimmune diseases [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | JNJ-64264681 is a potent, orally active, selective, and irreversible covalent inhibitor of Bruton's tyrosine kinase (BTK). This compound demonstrates favorable pharmacokinetic properties and is applicable in the research of cancer and autoimmune diseases [1]. |
分子量 | 518.63 |
分子式 | C27H30N6O3S |
CAS No. | 2101524-34-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JNJ-64264681 2101524-34-7 Angiogenesis Tyrosine Kinase/Adaptors BTK Inhibitor inhibitor inhibit